Survival score to characterize prognosis in inoperable stage III NSCLC after chemoradiotherapy

BACKGROUND: Stage III non-small cell lung cancer (NSCLC) represents a heterogeneous disease regarding principal patient- and tumor characteristics. A simple score may aid in personalizing multimodal therapy. METHODS: The data of 99 consecutive patients with performance status ECOG 0–1 treated until...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Transl Lung Cancer Res
Autores principales: Taugner, Julian, Käsmann, Lukas, Eze, Chukwuka, Dantes, Maurice, Roengvoraphoj, Olarn, Gennen, Kathrin, Karin, Monika, Petruknov, Oleg, Tufman, Amanda, Belka, Claus, Manapov, Farkhad
Formato: Artigo
Lenguaje:Inglês
Publicado: AME Publishing Company 2019
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6835102/
https://ncbi.nlm.nih.gov/pubmed/31737496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2019.09.19
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares